World's Best Scientists 2026 revealed!
Jennifer R. Brown

Jennifer R. Brown

D-Index & Metrics

Medicine

D-Index
97
Citations
39718
World Ranking
9184
National Ranking
4738

Jennifer R. Brown publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jennifer R. Brown sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 675 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jennifer R. Brown D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jennifer R. Brown sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2008 - Fellow of the Royal Society of Canada Academy of Social Sciences

Overview

Jennifer R. Brown is affiliated with Harvard University in the United States and has a research focus within the field of Medicine. Their work spans multiple subfields including Genetics, Pathology and Forensic Medicine, Immunology, Oncology, and Hematology.

Their main research topics include:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Advanced Breast Cancer Therapies
  • CAR-T cell therapy research
  • PI3K/AKT/mTOR signaling in cancer

Jennifer R. Brown has published extensively in various scientific journals. Frequent publication venues include:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Advances
  • Journal of Clinical Oncology
  • Hematological Oncology

Notable recent papers authored or coauthored by Jennifer R. Brown are:

  • "Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia," 2022, New England Journal of Medicine
  • "PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer," 2023, Molecular Cancer
  • "PI3K inhibitors are finally coming of age," 2021, Nature Reviews Drug Discovery
  • "Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study," 2021, The Lancet
  • "Outcomes of COVID-19 in patients with CLL: a multicenter international experience," 2020, Blood

Their frequent coauthors include:

  • Matthew S. Davids
  • Stacey M. Fernandes
  • Constantine S. Tam
  • Paolo Ghia
  • Wojciech Jurczak

Jennifer R. Brown received the award Fellow of the Royal Society of Canada in 2008, recognized by the Academy of Social Sciences.

Best Publications

  • Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

    Andrew W. Roberts;Matthew S. Davids;John M. Pagel;Brad S. Kahl

  • Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

    J. C. Byrd;J. R. Brown;Susan O'Brien;J. C. Barrientos

  • Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia

    Dan A. Landau;Scott L. Carter;Petar Stojanov;Petar Stojanov;Aaron McKenna

  • SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia

    Lili Wang;Michael S. Lawrence;Youzhong Wan;Petar Stojanov

  • Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

    John C. Byrd;Bonnie Harrington;Susan O'Brien;Jeffrey A. Jones

  • Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease

    Andrew W. Roberts;John F. Seymour;John F. Seymour;Jennifer R. Brown;William G. Wierda

  • Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

    Jennifer A Woyach;Amy S Ruppert;Nyla A Heerema;Weiqiang Zhao

  • Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

    Nicholas Kwiatkowski;Tinghu Zhang;Peter B. Rahl;Brian J Abraham

  • Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.

    Jennifer R. Brown;John C. Byrd;Steven E. Coutre;Don M. Benson

  • Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737

    Victoria Del Gaizo Moore;Jennifer R. Brown;Michael Certo;Tara M. Love

  • A Defect in Nurturing in Mice Lacking the Immediate Early Gene fosB

    Jennifer R Brown;Jennifer R Brown;Hong Ye;Hong Ye;Roderick T Bronson;Pieter Dikkes

  • Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

    Laura Z. Rassenti;Sonia Jain;Michael J. Keating;William G. Wierda

  • Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

    Akinori Yoda;Yuka Yoda;Sabina Chiaretti;Michal Bar-Natan

  • Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma

    Talha Munir;Jennifer R. Brown;Susan O'Brien;Jacqueline C. Barrientos

  • Locally Disordered Methylation Forms the Basis of Intratumor Methylome Variation in Chronic Lymphocytic Leukemia

    Dan Avi Landau;Dan Avi Landau;Kendell Clement;Kendell Clement;Kendell Clement;Michael Johannes Ziller;Michael Johannes Ziller;Patrick Boyle

  • Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.

    Susan O'Brien;Susan O'Brien;Jeffrey A Jones;Steven E Coutre;Anthony R Mato;Anthony R Mato

  • MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

    Lian Xu;Zachary R. Hunter;Guang Yang;Yangsheng Zhou

  • FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects.

    Noboru Hiroi;Jennifer R. Brown;Colin N. Haile;Hong Ye

  • Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition

    Jan A. Burger;Dan A. Landau;Amaro Taylor-Weiner;Ivana Bozic

  • Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.

    Anthony R Mato;Nirav N Shah;Wojciech Jurczak;Chan Y Cheah

Frequent Co-Authors

Donna Neuberg
Donna Neuberg Harvard University
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Susan O'Brien
Susan O'Brien University of California, Irvine
Thomas J. Kipps
Thomas J. Kipps University of California, San Diego
Catherine J. Wu
Catherine J. Wu Harvard University
Peter Hillmen
Peter Hillmen St James's University Hospital
Arnold S. Freedman
Arnold S. Freedman Harvard University
Richard R. Furman
Richard R. Furman NewYork–Presbyterian Hospital
Steven Coutre
Steven Coutre Stanford University
William G. Wierda
William G. Wierda The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking alternative or complementary career paths to medicine, a range of online degrees and bridge programs are available. For example, registered nurses wishing to advance their practice can explore rn to fnp programs, which allow RNs to become Family Nurse Practitioners through flexible, reputable online options.

Nutrition is another growing field. Those passionate about diet, wellness, and prevention can consider online degrees in nutrition as a foundation for careers as dietitians, health educators, or public health specialists.

Administration and leadership roles in healthcare are also accessible through quality online education. Prospective managers should look for which online healthcare administration programs have cahme accreditation? to ensure their degree meets high industry standards.

Additionally, nurses aiming to obtain a bachelor’s degree may benefit from rn to bsn programs no clinicals, which offer convenient and accelerated pathways without extra clinical requirements.

These options provide valuable, flexible career pathways for aspiring healthcare professionals who want alternatives to traditional, on-campus medical education in the USA.

Best Scientists Citing Jennifer R. Brown

Trending Scientists

Recently Published Articles